Recursion Pharmaceuticals Inc (NASDAQ: RXRX) – Suitable For Long Term Buy?
Currently, there are 183.21M common shares owned by the public and among those 151.91M shares have been available to trade. Insiders at the company have transacted a total of 143 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 61 of these insider trades were purchases, […]
Now Is A Suitable Moment For A Long-Term Purchase Of Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 183.21M common shares owned by the public and among those 151.89M shares have been available to trade. Insiders at the company have transacted a total of 153 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 65 of these insider trades were purchases, […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Reassessing Prospects
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Thursday at a closing price of $9.90, with 4.24 million shares of worth about $41.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.75% during that period and on Thursday the price saw a gain of […]
Stick With Recursion Pharmaceuticals Inc (RXRX). The Bull Are Alive And Well
ARK Investment Management LLC recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 200.36% to 20.65 million shares with purchase of 13.78 million shares. This fresh investment now brings its stake to 9.92% valued currently at $203.65 million. In addition, […]
Stick With Recursion Pharmaceuticals Inc (RXRX). The Bull Are Alive And Well
The Vanguard Group, Inc. recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 38.41% to 15.27 million shares with purchase of 4.24 million shares. This fresh investment now brings its stake to 7.33% valued currently at $104.6 million. In addition, […]
Recursion Pharmaceuticals Inc (RXRX): Street Finally Waking Up
The Vanguard Group, Inc. recently announced the acquisition of new stake in Recursion Pharmaceuticals Inc (NASDAQ:RXRX). The institutional investor has increased its shareholding in the Healthcare company by 38.41% to 15.27 million shares with purchase of 4.24 million shares. This fresh investment now brings its stake to 7.33% valued currently at $104.6 million. In addition, […]
